|
TC2N expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.486820E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.042600E-01 |
| Normal-vs-Stage2 |
1.975430E-01 |
| Normal-vs-Stage3 |
2.649700E-04 |
| Normal-vs-Stage4 |
4.588400E-02 |
| Stage1-vs-Stage2 |
6.150200E-01 |
| Stage1-vs-Stage3 |
1.612340E-04 |
| Stage1-vs-Stage4 |
1.945390E-01 |
| Stage2-vs-Stage3 |
1.053240E-01 |
| Stage2-vs-Stage4 |
4.346000E-01 |
| Stage3-vs-Stage4 |
5.052600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.116300E-02 |
| Normal-vs-AfricanAmerican |
6.173600E-01 |
| Normal-vs-Asian |
3.680200E-01 |
| Caucasian-vs-AfricanAmerican |
6.246100E-02 |
| Caucasian-vs-Asian |
9.766800E-01 |
| AfricanAmerican-vs-Asian |
5.619600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.023800E-02 |
| Normal-vs-Female |
3.278000E-01 |
| Male-vs-Female |
5.955800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.018430E-02 |
| Normal-vs-Extreme_Weight |
2.385700E-02 |
| Normal-vs-Obese |
4.482200E-01 |
| Normal-vs-Extreme_Obese |
2.789200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.706400E-01 |
| Normal_Weight-vs-Obese |
3.599600E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.844600E-01 |
| Extreme_Weight-vs-Obese |
1.308010E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.503200E-01 |
| Obese-vs-Extreme_Obese |
5.762400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.134800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.062400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.866000E-02 |
| Normal-vs-Age(81-100Yrs) |
1.474350E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.329600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.045000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.926100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.312400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.090100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.271600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.770850E-01 |
| Normal-VS-Type2 PRCC |
3.92420000000504E-05 |
| Normal-VS-KIRP CIMP |
8.971200E-01 |
| Normal-VS-Unclassified PRCC |
2.413600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.73149999999267E-06 |
| Type1 PRCC-VS-KIRP CIMP |
3.232000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.753000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.884200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.263700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.814400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.205200E-04 |
| Normal-vs-N1 |
4.479900E-02 |
| Normal-vs-N2 |
1.596030E-04 |
| N0-vs-N1 |
2.255000E-01 |
| N0-vs-N2 |
5.836600E-01 |
| N1-vs-N2 |
3.302000E-01 |
|
|
